Drug induced pseudolymphoma
- 1 July 2018
- journal article
- review article
- Published by Elsevier in Seminars in Diagnostic Pathology
- Vol. 35 (4) , 247-259
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Comparison of cytokine gene polymorphism in drug‐induced maculopapular eruption, urticaria and drug reaction with eosinophilia and systemic symptoms (DRESS)Journal of the European Academy of Dermatology and Venereology, 2013
- HLA alleles and drug hypersensitivity reactionsInternational Journal of Immunogenetics, 2011
- Drug‐associated reversible granulomatous T cell dyscrasia: a distinct subset of the interstitial granulomatous drug reactionJournal of Cutaneous Pathology, 2010
- T- and B-cell clonally restricted pseudolymphoma in the setting of phytoestrogen therapyJournal of the European Academy of Dermatology and Venereology, 2008
- Assessment of TCR‐β clonality in a diverse group of cutaneous T‐Cell infiltratesJournal of Cutaneous Pathology, 2008
- Lymphomatoid contact dermatitis to an exotic wood: a very harmful toilet seatContact Dermatitis, 2007
- Cutaneous marginal zone B‐cell lymphoma in the setting of fluoxetine therapy: a hypothesis regarding pathogenesis based on in vitro suppression of T‐cell‐proliferative responseJournal of Cutaneous Pathology, 2006
- Drug-Induced Hypersensitivity Syndrome Associated with Cytomegalovirus Reactivation: Immunological Characterization of Pathogenic T CellsActa Dermato-Venereologica, 2005
- Lymphomatoid contact dermatitis caused by isopropyl-diphenylenediamine: Two casesJournal of Allergy and Clinical Immunology, 1998
- Generalized cutaneous B-cell pseudolymphoma induced by neurolepticsArchives of Dermatology, 1992